ADVICE
Final diagnosis should be made with clinical interview and mental status
examination
including assessment of patient’s level of distress and functional
impairment.
MANAGEMENT
PHQ-9 Management Summary
Score |
Depression severity |
Comments |
0-4 |
Minimal or none |
Monitor; may not require
treatment |
5-9 |
Mild |
Use clinical judgment
(symptom duration, functional impairment) to determine necessity
of
treatment |
10-14 |
Moderate |
15-19 |
Moderately severe |
Warrants active
treatment
with psychotherapy, medications, or combination |
20-27 |
Severe |
CRITICAL ACTIONS
- Perform suicide risk assessment in patients who respond positively to item 9
“Thoughts that you would be better off dead or of hurting yourself in some
way.”
- Rule out bipolar disorder, normal bereavement, and medical disorders causing
depression.
FORMULA
Addition of the selected points.
FACTS & FIGURES
The PHQ-9 is a validated, 9-question tool to assess for the degree of depression
present in an individual; the last question is not scored, but is useful
functionally to help the clinician assess the impact of the patient's symptoms on
his or her life.
EVIDENCE APPRAISAL
The PHQ-9 was initially developed by Kroenke et al (2001), as a subset of 9
questions from the full PHQ, which had previously been derived and studied in a
cohort of 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology
clinics (Spitzer 1999). PHQ-9 scores ≥10 were found to be 88% sensitive and also 88%
specific for detecting MDD. Criterion validity was also assessed in a sample of 580
patients.
The PHQ-9 has also been validated in several additional subpopulations, including in
psychiatric patients (Beard 2016), patients with medical comorbidities such as
multiple sclerosis (Ferrando 2007) and Parkinson’s disease (Chagas 2013), pregnant
patients (Sidebottom 2012), and in an occupational health setting (Volker 2016).
A meta-analysis of 29 studies including 6,725 patients found similar sensitivity
(88%, 95% CI 83-92%) and specificity (85%, 95% CI 82-88%) for a cutoff of ≥10 as did
the previous studies, both overall and for subgroups. Notably, they found that when
used in the primary care setting, only approximately 50% of patients screening
positive on the PHQ-9 in fact had major depression (Levis 2019).